Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease
Alcalay
Roy Nissim
author
Columbia University. Center for Parkinson's Disease and Other Movement Disorders
Mejia-Santana
Helen
author
Columbia University. Sergievsky Center
Tang
Ming Xin
author
Columbia University. Biostatistics
Rosado
Llency E.
author
Columbia University. Sergievsky Center
Verbitsky
Miguel
author
Kisselev
Sergey
author
Columbia University. Pathology and Cell Biology
Ross
Barbara M.
author
Columbia University. Taub Institute
Louis
Elan D.
author
Columbia University. Center for Parkinson's Disease and Other Movement Disorders
Columbia University. Epidemiology
Comella
Cynthia L.
author
Colcher
Amy
author
Jennings
Danna
author
Nance
Martha A.
author
Bressman
Susan
author
Scott
William K.
author
Tanner
Caroline
author
Mickel
Susan F.
author
Andrews
Howard F.
author
Columbia University. Biostatistics
Waters
Cheryl H.
author
Columbia University. Center for Parkinson's Disease and Other Movement Disorders
Fahn
Stanley
author
Columbia University. Center for Parkinson's Disease and Other Movement Disorders
Cote
Lucien J.
author
Columbia University. Neurology
Frucht
Steven
author
Columbia University. Neurology
Ford
Blair
author
Columbia University. Center for Parkinson's Disease and Other Movement Disorders
Rezak
Michael
author
Novak
Kevin
author
Friedman
Joseph H.
author
Pfeiffer
Ronald
author
Marsh
Laura
author
Hiner
Bradley
author
Siderowf
Andrew
author
Van Vliet
Elise A.
author
Columbia University. Neurology
Ottman
Ruth
author
Columbia University. Epidemiology
Clark
Lorraine N.
author
Columbia University. Pathology and Cell Biology
Marder
Karen
author
Columbia University. Neurology
Columbia University. Center for Parkinson's Disease and Other Movement Disorders
originator
text
Articles
2009
manuscript version
English
Objective: To determine the motor phenotype of LRRK2 G2019S mutation carriers. LRRK2 mutation carriers were previously reported to manifest the tremor dominant motor phenotype, which has been associated with slower motor progression and less cognitive impairment compared with the postural instability and gait difficulty (PIGD) phenotype. Design: Cross-sectional observational study. Setting: Thirteen movement disorders centers. Participants: Nine hundred twenty-five early-onset Parkinson disease cases defined as age at onset younger than 51 years. Main Outcome Measures: LRRK2 mutation status and Parkinson disease motor phenotype: tremor dominant or PIGD. Demographic information, family history of Parkinson disease, and the Unified Parkinson's Disease Rating Scale score were collected on all participants. DNA samples were genotyped for LRRK2 mutations (G2019S, I2020T, R1441C, and Y1699C). Logistic regression was used to examine associations of G2019S mutation status with motor phenotype adjusting for disease duration, Ashkenazi Jewish ancestry, levodopa dose, and family history of Parkinson disease. Results: Thirty-four cases (3.7%) (14 previously reported) were G2019S carriers. No other mutations were found. Carriers were more likely to be Ashkenazi Jewish (55.9% vs 11.9%; P < .001) but did not significantly differ in any other demographic or disease characteristics. Carriers had a lower tremor score (P = .03) and were more likely to have a PIGD phenotype (92.3% vs 58.9%; P = .003). The association of the G2019S mutation with PIGD phenotype remained after controlling for disease duration and Ashkenazi Jewish ancestry (odds ratio, 17.7; P < .001). Conclusion: Early-onset Parkinson disease G2019S LRRK2 carriers are more likely to manifest the PIGD phenotype, which may have implications for disease course.
Neurosciences
Archives of neurology
66
12
1442
1444
2009
0003-9942
http://dx.doi.org/10.1001/archneurol.2009.267
http://hdl.handle.net/10022/AC:P:9929
NNC
NNC
2011-03-10 10:01:55 -0500
2012-08-28 16:51:31 -0400
3054
eng